Dr. Pritesh Kumar, Ph.D.

Job Title: Consultant
Company: PhytoSciences Consulting LLC
Specialization: Cannabinoid Pharmacology & Toxicology
Location: Residing in Switzerland with Offices in USA
Website: www.phytosciences.com

Favorite Quote:
“All things are poison and nothing is without poison; only the dose makes a thing not a poison.”
Dr. Pritesh Kumar earned his Ph.D. in Pharmacology and Toxicology, with a focus in cannabinoid (cannabis) pharmacology, from the University of Louisville, Kentucky USA. Previously, Dr. Kumar conducted pharmacological testing of FDA- approved drugs as potential ligands for the cannabinoid receptor 2 (CB2) and investigated the pharmacology of cannabinoids.Dr. Kumar is currently an Advisor to the WHO (World Health Organization) based in Geneva, Switzerland. In this role, Dr. Kumar provides consultation services to the 40th Meeting of the Expert Committee on Drug Dependence regarding Cannabis Toxicology.Dr. Kumar is the Senior Managing Director of PhytoSciences, an international organization comprised of 40+ scientists based in India, Canada, Africa, Latin America, and the USA. The company consults in the areas clinical trial solutions, novel drug delivery technology
development, industrial scale manufacturing, analytical testing, and commercial bioprocessing.Dr. Kumar is currently the Scientific Advisor for Addis Ababa University, School of Pharmacy (SoP) in Ethiopia. In this role, Dr. Kumar facilitates advancements in graduate student education, promotes the interest of the SoP, and develops relationships between the SoP and
the private sector.

In addition, Dr. Kumar previously served as Chief Scientific Officer for PharmaCielo Ltd., a Canadian company with operations in Colombia, South America. Dr. Kumar was responsible for the company’s R&D, global business product development strategy, and Phase I development
of a state-of-the-art bioprocessing plant.

He was previously the Chair of PharmaCielo’s Research Advisory Board and worked closely with the Medical Advisory Board, headquartered
in Geneva, Switzerland, to coordinate clinical programs for cannabinoid-based therapeutics.

Dr. Kumar previously served as a Scientific Advisor to Revive Therapeutics, a Canadian Pharmaceutical company, advancing R & D of novel plant-based research initiatives, with an initial focus on cannabinoids and the liver. Dr. Kumar managed public private partnerships with academic institutions and commercialization / licensing of drug-delivery

He has received numerous honors and awards including Best Oral Presentation from the International Cannabinoid Research Society (ICRS) Conference in Vancouver and fellowships from Drug Discovery and Target in Boston and Integrated Programs in Biomedical Sciences (IPIBS) as well as travel awards from the National Institute on Drug Abuse and University of Louisville School of Medicine for his presentations in the
U.S., Canada, Italy, and Germany.

Dr. Kumar has been published in numerous scientific journals including the European Journal of Pharmacology, Pharmacology and Physiology, Journal of Medicinal Chemistry, Investigative Ophthalmology & Visual Science and Biochemical and Biophysical Research Communications .